As a condition of gaining access to classified information, many government employees agree to submit to official pre-publication review of any public statement they wish to make that is related to their government employment.
This procedure has long been a source of conflict and controversy, but over time the pre-publication review process has become increasingly onerous, internally contradictory, and disruptive.
As part of an ongoing dialog on the subject, I offered some thoughts on “Fixing Pre-Publication Review: What Should Be Done?” on the Just Security blog.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.
Called today to speak on behalf of U.S. science and technology, Dr. Jedidah Isler, astrophysicist, educator, strategist, policy-maker, and science communicator, will provide constructive, nonpartisan feedback to the House Committee’s hearing “American Global Competitiveness at 250: Legislative Proposals to Secure U.S. Technology Leadership.”
“Federal data and access to it is not a partisan issue. It is a people issue. Our country cannot achieve greatness without access to the data that measure what we value, who we are, and where we’re heading.”
The United States’ biosecurity governance system is structurally incapable of detecting and responding to certain classes of threats. U.S. biosecurity tools have not kept pace with technological advancements or a changing threat landscape.